ANTITHYROID ANTIBODY (ANTI-TPO) - ANVISA Registration 10345160294

Access comprehensive regulatory information for ANTITHYROID ANTIBODY (ANTI-TPO) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345160294 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345160294
Registration Details
ANVISA Registration Number: 10345160294
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

QC ANTI-TPO 1, 2 ADVIA CENTAUR ACS 180 SYSTEMS
Risk Class II

Registration Details

10345160294

25351163479200213

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 12, 2002

VIGENTE

09/18/2025 19:00:01